These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 169311)

  • 21. Absence of idoxuridine and persistence of herpes simplex virus in brains of patients being treated for encephalitis.
    Lauter CB; Bailey EJ; Lerner AM
    Proc Soc Exp Biol Med; 1975 Oct; 150(1):23-7. PubMed ID: 171683
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Idoxuridine treatment of herpes virus infections].
    Wildenhoff KE; Esmann V
    Ugeskr Laeger; 1979 May; 141(19):1288-9. PubMed ID: 222029
    [No Abstract]   [Full Text] [Related]  

  • 23. Disseminated herpes-simplex-virus infections.
    Nahmias AJ
    N Engl J Med; 1970 Mar; 282(12):684-5. PubMed ID: 4190592
    [No Abstract]   [Full Text] [Related]  

  • 24. Experimental encephalitis caused by herpes simplex virus: comparison of treatment with tilorone hydrochloride and phosphonoacetic acid.
    Fitzwilliam JF; Griffith JF
    J Infect Dis; 1976 Jun; 133 Suppl():A221-5. PubMed ID: 180204
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Virus diseases.
    Juel-Jensen BE
    Practitioner; 1974 Oct; 213(1276 SPEC NO):508-18. PubMed ID: 4376235
    [No Abstract]   [Full Text] [Related]  

  • 26. Taratogenic effects of the pyrimidine analogues 5-iododeoxyuridine and cytosine arabinoside in late fetal mice and rats.
    Percy DH
    Teratology; 1975 Feb; 11(1):103-17. PubMed ID: 806125
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of herpesvirus encephalitis.
    Rappel M
    Lancet; 1971 May; 1(7706):971. PubMed ID: 4102297
    [No Abstract]   [Full Text] [Related]  

  • 28. [Biological and medical significance of Herpetic viruses III. Defense mechanisms of the organism and the current status of using antiviral substances].
    Szántó J; Rajcáni J
    Bratisl Lek Listy; 1976 Jun; 65(6):687-9. PubMed ID: 184889
    [No Abstract]   [Full Text] [Related]  

  • 29. Herpes simplex virus latency in cultured human cells following treatment with cytosine arabinoside.
    O'Neill FJ; Goldberg RJ; Rapp F
    J Gen Virol; 1972 Feb; 14(2):189-97. PubMed ID: 4334781
    [No Abstract]   [Full Text] [Related]  

  • 30. Inhibition of oral shedding of herpes simplex virus by cytosine arabinoside.
    Mankad VN; Gershon AA; Brunell PA
    J Infect Dis; 1973 Apr; 127(4):442-4. PubMed ID: 4348497
    [No Abstract]   [Full Text] [Related]  

  • 31. Editorial: Hepatitis and herpesvirus.
    Br Med J; 1974 Aug; 3(5929):484. PubMed ID: 4369945
    [No Abstract]   [Full Text] [Related]  

  • 32. [Acquired idoxuridine resistance of herpes simplex virus. Clinical data (author's transl)].
    Colin J; Chastel C
    Sem Hop; 1978 Oct 18-25; 54(33-36):1071-2. PubMed ID: 220719
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Editorial comment: antiviral chemotherapy.
    Plotkin SA
    J Pediatr; 1972 Mar; 80(3):493-5. PubMed ID: 4334179
    [No Abstract]   [Full Text] [Related]  

  • 34. Latent herpes simplex virus infections in sensory ganglia of mice after topical treatment with adenine arabinoside and adenine arabinoside monophosphate.
    Klein RJ; Friedman-Kien AE
    Antimicrob Agents Chemother; 1977 Nov; 12(5):577-81. PubMed ID: 200172
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of activity of herpes virus inhibitors.
    Collins P; Bauer DJ
    J Antimicrob Chemother; 1977 Mar; 3 Suppl A():73-81. PubMed ID: 405365
    [No Abstract]   [Full Text] [Related]  

  • 36. Letter: Therapy of herpes simplex virus encephalitis.
    N Engl J Med; 1975 Jun; 292(25):1354-5. PubMed ID: 165413
    [No Abstract]   [Full Text] [Related]  

  • 37. Antiherpesvirus activity in human sera and urines after administration of adenine arabinoside: in vitro and in vivo synergy of adenine arabinoside and arabinosylhypoxanthine in combination.
    Champney KJ; Lauter CB; Bailey EJ; Lerner AM
    J Clin Invest; 1978 Dec; 62(6):1142-53. PubMed ID: 219024
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of infections due to Herpesvirus in humans: a critical review of the state of the art.
    Alford CA; Whitley RJ
    J Infect Dis; 1976 Jun; 133 Suppl():A101-8. PubMed ID: 180191
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intracerebroventricular and intraperitoneal disodium phosphonoacetate treatment of herpes simplex virus type I experimental encephalitis in rats.
    Aoki FY; Trépanier G; Lussier G
    J Infect Dis; 1979 Feb; 139(2):158-65. PubMed ID: 220332
    [No Abstract]   [Full Text] [Related]  

  • 40. Effect of cytosine, arabinoside, iododeoxyuridine, ethyldeoxyuridine, thiocyanatodeoxyuridine, and ribavirin on tail lesion formation in mice infected with vaccinia virus.
    De Clercq E; Luczak M; Shugar D; Torrence PF; Waters JA; Witkop B
    Proc Soc Exp Biol Med; 1976 Mar; 151(3):487-90. PubMed ID: 1257248
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.